Precision Repair for High-Risk Patients: The NovoClasp Transcatheter Mitral Valve Clip System from Enlight Medical Is Approved by NMPA
May 1, 2026
The NovoClasp Transcatheter Mitral Valve Clip System is a breakthrough device that offers a life-changing, minimally invasive alternative for patients suffering from severe degenerative mitral regurgitation (MR ≥3+) who are considered high-risk for open-heart surgery.
Sophisticated Engineering for Complex Anatomy NovoClasp is designed for “edge-to-edge” repair, delivered via a percutaneous route through the femoral vein. Its state-of-the-art delivery system provides clinicians with unprecedented control to ensure optimal placement and maximum reduction of regurgitation.
Product Highlights:
- Tailored Control: Offers both Type I (synchronized) and Type II (independent) leaflet control systems to adapt to unique patient anatomies.
- Minimally Invasive: Uses a percutaneous approach that significantly reduces surgical trauma and shortens recovery times.
- Quality of Life: Proven to alleviate debilitating symptoms such as shortness of breath and fatigue, helping patients return to an active lifestyle.
- Verified Durability: The system has undergone rigorous stability and aging validation to ensure a reliable 2-year shelf life.
NovoClasp represents our commitment to providing high-fidelity cardiac solutions for the most vulnerable patient populations.